{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T09:18:14Z","timestamp":1783588694264,"version":"3.55.0"},"reference-count":44,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"unspecified","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Hunan Province Health Special Fund Research Topic, China","award":["A2023-06"],"award-info":[{"award-number":["A2023-06"]}]},{"name":"Independent Exploration and Innovation Project of Central South University Graduate Students","award":["2025ZZTS0824"],"award-info":[{"award-number":["2025ZZTS0824"]}]},{"name":"Hunan Provincial Key R and D Program, China","award":["2021SK2024"],"award-info":[{"award-number":["2021SK2024"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,3,12]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Early screening of non-alcoholic fatty liver disease (NAFLD) is critical for early diagnosis and management. The disease was renamed and its diagnostic criteria revised as metabolic-associated FLD (MAFLD) in 2020 and further updated to metabolic dysfunction-associated steatotic liver disease (MASLD) in 2023. This study evaluated the predictive performance and clinical feasibility of non-invasive diagnostic indicators across the NAFLD, MAFLD and MASLD diagnostic criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Cross-sectional study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Health Management Centre in China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>A total of 5810 participants aged \u226518 years were enrolled. Individuals with missing laboratory data, imaging results or self-reported information were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>Disease-specific indicators included Fatty Liver Index (FLI), Hepatic Steatosis Index and Zhejiang University index (ZJU). Non-disease-specific indicators included lipid accumulation product (LAP), Visceral Adiposity Index and the Triglyceride and Glucose Index. Subgroup analysis was performed by gender and Body Mass Index (BMI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The area under the receiver operating characteristic curve (AUROC) for all six non-invasive indicators exceeded 0.7. FLI showed the optimal predictive performance across the three criteria (NAFLD-AUROC: 0.802, MAFLD-AUROC: 0.847 and MASLD-AUROC: 0.811), with comparable performance observed for ZJU (0.797, 0.838 and 0.809, respectively). Pairwise z-tests demonstrated a significant difference between FLI and ZJU for MAFLD (p&lt;0.05), but not for NAFLD or MASLD (all p&gt;0.05). Subgroup analyses revealed that ZJU performed better in males (NAFLD-AUROC: 0.790, MAFLD-AUROC: 0.839 and MASLD-AUROC: 0.803), while FLI was superior in females (NAFLD-AUROC: 0.832, MAFLD-AUROC: 0.838 and MASLD-AUROC: 0.838) and in participants who were overweight (NAFLD-AUROC: 0.709, MAFLD-AUROC: 0.765 and MASLD-AUROC: 0.709). LAP exhibited the highest predictive efficacy in the normal BMI subgroup (NAFLD-AUROC: 0.758, MAFLD-AUROC: 0.804 and MASLD-AUROC: 0.796).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>FLI exhibited the highest predictive efficacy across all diagnostic criteria, and ZJU showed comparable performance. Considering diagnostic accuracy and clinical practicality, ZJU is recommended as a favourable, non-invasive tool for population-based screening in the Chinese population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-094809","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T16:10:30Z","timestamp":1775146230000},"page":"e094809","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of the identification and practicability of non-invasive diagnostic indicators under NAFLD, MAFLD and MASLD in China: a cross-sectional study"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5555-6750","authenticated-orcid":false,"given":"Xin-Yun","family":"Tan","sequence":"first","affiliation":[{"name":"Xiangya School of Nursing, Central South University, Changsha, Hunan, China"},{"name":"Health Management Medicine Center and Nursing Department, Third Xiangya Hospital of Central South University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Hui","family":"Zou","sequence":"additional","affiliation":[{"name":"School of Nursing, Jishou University, Jishou, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjuan","family":"Huang","sequence":"additional","affiliation":[{"name":"Xiangya School of Nursing, Central South University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Jie","family":"Guo","sequence":"additional","affiliation":[{"name":"Xiangya School of Nursing, Central South University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruo-Ling","family":"Yu","sequence":"additional","affiliation":[{"name":"Xiangya School of Nursing, Central South University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Lian","family":"Liu","sequence":"additional","affiliation":[{"name":"Health Management Medicine Center and Nursing Department, Third Xiangya Hospital of Central South University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1687-8352","authenticated-orcid":false,"given":"Ting","family":"Peng","sequence":"additional","affiliation":[{"name":"Health Management Medicine Center and Nursing Department, Third Xiangya Hospital of Central South University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Xiangya Hospital of Central South University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Xiang","family":"Qin","sequence":"additional","affiliation":[{"name":"Health Management Medicine Center and Nursing Department, Third Xiangya Hospital of Central South University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"2026070902001839000_16.4.e094809.1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431"},{"key":"2026070902001839000_16.4.e094809.2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29367"},{"key":"2026070902001839000_16.4.e094809.3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.11.312"},{"key":"2026070902001839000_16.4.e094809.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.039"},{"key":"2026070902001839000_16.4.e094809.5","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000520"},{"key":"2026070902001839000_16.4.e094809.6","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.03.005"},{"key":"2026070902001839000_16.4.e094809.7","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1007\/s12325-021-01690-1","article-title":"Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management","volume":"38","author":"Lonardo","year":"2021","journal-title":"Adv Ther"},{"key":"2026070902001839000_16.4.e094809.8","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3748\/wjg.v25.i11.1307","article-title":"Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice","volume":"25","author":"Zhou","year":"2019","journal-title":"WJG"},{"key":"2026070902001839000_16.4.e094809.9","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.3350\/cmh.2024.1165","article-title":"What is new in the 2024 Chinese guidelines for fatty liver disease?","volume":"31","author":"Yang","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"2026070902001839000_16.4.e094809.10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/liv.13970","article-title":"Reducing NAFLD-screening time: A comparative study of eight diagnostic methods offering an alternative to ultrasound scans","volume":"39","author":"Procino","year":"2019","journal-title":"Liver Int"},{"key":"2026070902001839000_16.4.e094809.11","doi-asserted-by":"crossref","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"2026070902001839000_16.4.e094809.12","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13063"},{"key":"2026070902001839000_16.4.e094809.13","doi-asserted-by":"crossref","first-page":"16494","DOI":"10.1038\/srep16494","article-title":"ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population","volume":"5","author":"Wang","year":"2015","journal-title":"Sci Rep"},{"key":"2026070902001839000_16.4.e094809.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2009.08.002"},{"key":"2026070902001839000_16.4.e094809.15","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-023-01802-6","article-title":"Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis","volume":"22","author":"Ebrahimi","year":"2023","journal-title":"Lipids Health Dis"},{"key":"2026070902001839000_16.4.e094809.16","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2261-5-26","article-title":"The \u201clipid accumulation product\u201d performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison","volume":"5","author":"Kahn","year":"2005","journal-title":"BMC Cardiovasc Disord"},{"key":"2026070902001839000_16.4.e094809.17","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1825"},{"key":"2026070902001839000_16.4.e094809.18","doi-asserted-by":"publisher","DOI":"10.1089\/met.2008.0034"},{"key":"2026070902001839000_16.4.e094809.19","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-014-0154-x","article-title":"Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA","volume":"12","author":"Cheung","year":"2014","journal-title":"BMC Med"},{"key":"2026070902001839000_16.4.e094809.20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000443344","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease","volume":"9","year":"2016","journal-title":"Obes Facts"},{"key":"2026070902001839000_16.4.e094809.21","unstructured":"Thomas FB , John CH , John BS , et al . The alcohol use disorders identification test, guidelines for use in primary care. World Health Organization, Department of Mental Health and Substance Dependence: Whqlibdoc, 2001. Available: https:\/\/www.who.int\/publications\/i\/item\/WHO-MSD-MSB-01.6a.pdf"},{"key":"2026070902001839000_16.4.e094809.22","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3748\/wjg.v20.i2.475","article-title":"Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"20","author":"Sumida","year":"2014","journal-title":"WJG"},{"key":"2026070902001839000_16.4.e094809.23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12986-017-0206-2","article-title":"Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults","volume":"14","author":"Dai","year":"2017","journal-title":"Nutr Metab (Lond)"},{"key":"2026070902001839000_16.4.e094809.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.12.022"},{"key":"2026070902001839000_16.4.e094809.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.12.031"},{"key":"2026070902001839000_16.4.e094809.26","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1111\/liv.12305","article-title":"How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound","volume":"34","author":"Carvalhana","year":"2014","journal-title":"Liver Int"},{"key":"2026070902001839000_16.4.e094809.27","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13012"},{"key":"2026070902001839000_16.4.e094809.28","doi-asserted-by":"publisher","DOI":"10.1080\/10715760410001694026"},{"key":"2026070902001839000_16.4.e094809.29","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e328354044a"},{"key":"2026070902001839000_16.4.e094809.30","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.4254\/wjh.v8.i36.1610","article-title":"Fractionation of gamma-glutamyltransferase in patients with nonalcoholic fatty liver disease and alcoholic liver disease","volume":"8","author":"Sueyoshi","year":"2016","journal-title":"World J Hepatol"},{"key":"2026070902001839000_16.4.e094809.31","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-023-01850-y","article-title":"Development and validation of a nomogram for predicting metabolic-associated fatty liver disease in the Chinese physical examination population","volume":"22","author":"Zhou","year":"2023","journal-title":"Lipids Health Dis"},{"key":"2026070902001839000_16.4.e094809.32","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.cgh.2021.11.038","article-title":"An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD","volume":"21","author":"Lim","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026070902001839000_16.4.e094809.33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)15268-3"},{"key":"2026070902001839000_16.4.e094809.34","doi-asserted-by":"crossref","DOI":"10.1186\/s13098-022-00814-z","article-title":"NAFLD in normal weight individuals","volume":"14","author":"DiStefano","year":"2022","journal-title":"Diabetol Metab Syndr"},{"key":"2026070902001839000_16.4.e094809.35","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.06.023"},{"key":"2026070902001839000_16.4.e094809.36","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MOG.0000000000000920","article-title":"Metabolic dysfunction and nonalcoholic fatty liver disease risk in individuals with a normal body mass index","volume":"39","author":"DiStefano","year":"2023","journal-title":"Curr Opin Gastroenterol"},{"key":"2026070902001839000_16.4.e094809.37","doi-asserted-by":"crossref","first-page":"15489","DOI":"10.3390\/ijms232415489","article-title":"Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment","volume":"23","author":"Guo","year":"2022","journal-title":"IJMS"},{"key":"2026070902001839000_16.4.e094809.38","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1016\/j.jhep.2023.07.035","article-title":"What\u2019s in a name? New nomenclature for steatotic liver disease - to be or not to be?","volume":"80","author":"Semmler","year":"2024","journal-title":"J Hepatol"},{"key":"2026070902001839000_16.4.e094809.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.09.020"},{"key":"2026070902001839000_16.4.e094809.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.04.001"},{"key":"2026070902001839000_16.4.e094809.41","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/jgh.16199","article-title":"Alcohol, the gut microbiome, and liver disease","volume":"38","author":"Jew","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"key":"2026070902001839000_16.4.e094809.42","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-023-00822-y"},{"key":"2026070902001839000_16.4.e094809.43","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.16.1789"},{"key":"2026070902001839000_16.4.e094809.44","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10020346","article-title":"Association of NAFLD and Insulin Resistance with Non Metastatic Bladder Cancer Patients: A Cross-Sectional Retrospective Study","volume":"10","author":"Tarantino","year":"2021","journal-title":"J Clin Med"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-094809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T09:00:42Z","timestamp":1783587642000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-094809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,2]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/bmjopen-2024-094809"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-094809","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}